Department of Health and Human Services June 2023 – Federal Register Recent Federal Regulation Documents

Results 101 - 150 of 294
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting
Document Number: 2023-13209
Type: Notice
Date: 2023-06-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Aging; Notice of Closed Meeting
Document Number: 2023-13208
Type: Notice
Date: 2023-06-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of General Medical Sciences Notice of Proposed Reorganization
Document Number: 2023-13203
Type: Notice
Date: 2023-06-22
Agency: Department of Health and Human Services, National Institutes of Health
The National Institute of General Medical Sciences (NIGMS) will host two public online forums to enable public discussion of the Institute's proposal to reorganize its Division for Capacity Research Building (DRCB) and Division of Pharmacology, Physiology, and Biological Chemistry (PPBC) by creating a new branch in each division.
Fiscal Year (FY) 2023 Notice of Supplemental Funding Opportunity
Document Number: 2023-13146
Type: Notice
Date: 2023-06-21
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting one administrative supplement in scope of the parent award to the State Opioid Response (SOR)/Tribal Opioid Response (TOR) Technical Assistance Grant recipient, the American Academy of Addiction Psychiatry (AAAP) funded in FY 2022 under Notice of Funding Opportunity (NOFO) TI-22-007 to provide training and technical assistance to federally-recognized Tribes and Tribal organizations.
Fiscal Year (FY) 2023 Notice of Supplemental Funding Opportunity
Document Number: 2023-13145
Type: Notice
Date: 2023-06-21
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
This notice is to inform the public that the Substance Abuse and Mental Health Services Administration (SAMHSA) is supporting administrative supplements (in the scope of the parent award) for the 60 eligible grant recipients funded in FY 2023 under the Substance Use Prevention, Treatment, and Recovery Services Block Grant (SUBG). Recipients may receive an amount of between $25,000 and $2,089,193 for a total of $15,400,000. If all eligible SUBG recipients do not apply, remaining funds will be redistributed to applicants. These recipients have a project end date of September 30, 2024. The supplemental funding will be used for providing and/or obtaining training and technical assistance, or workforce development meetings and activities.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2023-13103
Type: Notice
Date: 2023-06-21
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
National Institute of Biomedical Imaging and Bioengineering; Notice of Proposed Reorganization
Document Number: 2023-13099
Type: Notice
Date: 2023-06-21
Agency: Department of Health and Human Services, National Institutes of Health
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) will host a public online forum to enable public discussion of the Institute's proposal to establish the Section on Mechanics and Tissue Remodeling Integrating Computational & Experimental Systems (MATRICES). The proposed reorganization will more accurately reflect the current structure by which the Intramural Research Program is functioning and improve the coordination of the scientific activities within the Institute. The online forum will allow members of the public to review the reorganization proposal and submit comments.
PHM Brands; Filing of Food Additive Petition
Document Number: 2023-13120
Type: Proposed Rule
Date: 2023-06-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by PHM Brands, proposing that the food additive regulation for chlorine dioxide be amended to provide for an additional method for producing the additive.
National Institute of Biomedical Imaging and Bioengineering Notice of Proposed Reorganization
Document Number: 2023-13098
Type: Notice
Date: 2023-06-21
Agency: Department of Health and Human Services, National Institutes of Health
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) will host a public online forum to enable public discussion of the Institute's proposal to establish the Section on Mechanics and Tissue Remodeling Integrating Computational & Experimental Systems (MATRICES). The proposed reorganization will more accurately reflect the current structure by which the Intramural Research Program is functioning and improve the coordination of the scientific activities within the Institute. The online forum will allow members of the public to review the reorganization proposal and submit comments.
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2023-13142
Type: Notice
Date: 2023-06-21
Agency: Department of Health and Human Services, National Institutes of Health
Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
Document Number: 2023-13136
Type: Notice
Date: 2023-06-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) announces a forthcoming public advisory committee meeting of the Circulatory System Devices Panel of the Medical Devices Advisory Committee. The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. The meeting will be open to the public.
Daylen Diaz: Final Debarment Order
Document Number: 2023-13135
Type: Notice
Date: 2023-06-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) permanently debarring Daylen Diaz from providing services in any capacity to a person that has an approved or pending drug product application. FDA bases this order on a finding that Daylen Diaz was convicted of a felony under Federal law for conduct relating to the development or approval, including the process for development or approval, of any drug product under the FD&C Act. Daylen Diaz was given notice of the proposed permanent debarment and was given an opportunity to request a hearing to show why she should not be debarred. As of February 26, 2023 (30 days after receipt of the notice), Ms. Diaz had not responded. Ms. Diaz' failure to respond and request a hearing within the prescribed timeframe constitutes a waiver of her right to a hearing concerning this action.
Oncology Drug Products Used With Certain In Vitro Diagnostic Tests: Pilot Program; Guidance for Industry, Clinical Laboratories, and Food and Drug Administration Staff; Availability
Document Number: 2023-13134
Type: Notice
Date: 2023-06-21
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry, clinical laboratories, and FDA staff entitled ``Oncology Drug Products Used with Certain In Vitro Diagnostic Tests: Pilot Program.'' FDA is issuing this guidance to announce and describe FDA's voluntary pilot program for certain oncology drug products regulated by FDA's Center for Drug Evaluation and Research (CDER) used with certain in vitro diagnostic tests. FDA intends to pilot a new approach to provide greater transparency regarding performance characteristics that certain tests for oncology biomarkers should meet. Through this transparency FDA seeks to support better and more consistent performance of certain laboratory-developed tests (LDTs) used to identify patients for treatment with certain oncology drug products, resulting in better drug selection and improved care for patients with cancer. The guidance has been implemented without prior comment, but remains subject to comment in accordance with the Agency's good guidance practices.
Agency Information Collection Request; 30-Day Public Comment Request
Document Number: 2023-13173
Type: Notice
Date: 2023-06-21
Agency: Department of Health and Human Services
In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment.
National Center for Advancing Translational Sciences; Notice of Closed Meeting
Document Number: 2023-13184
Type: Notice
Date: 2023-06-21
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Document Number: 2023-13183
Type: Notice
Date: 2023-06-21
Agency: Department of Health and Human Services, National Institutes of Health
Submission for OMB Review; Tribal Maternal, Infant, and Early Childhood Home Visiting Program Data Reports: Demographic and Service Utilization, Grantee Performance Measures, and Quarterly Performance Reports
Document Number: 2023-13065
Type: Notice
Date: 2023-06-20
Agency: Department of Health and Human Services, Administration for Children and Families
The Administration for Children and Families (ACF) is requesting a new information collection for the Tribal Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Tribal Home Visiting Program Data Reports: Demographic and Service Utilization, Grantee Performance Measures, and Quarterly Performance Reports.
Medicaid and Children's Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2023-13063
Type: Notice
Date: 2023-06-20
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
On May 28, 2010, the Office of Management and Budget (OMB) issued Paperwork Reduction Act (PRA) guidance related to the ``generic'' clearance process. Generally, this is an expedited process by which agencies may obtain OMB's approval of collection of information requests that are ``usually voluntary, low-burden, and uncontroversial collections,'' do not raise any substantive or policy issues, and do not require policy or methodological review. The process requires the submission of an overarching plan that defines the scope of the individual collections that would fall under its umbrella. On October 23, 2011, OMB approved our initial request to use the generic clearance process under control number 0938-1148 (CMS-10398). It was last approved on April 26, 2021, via the standard PRA process which included the publication of 60- and 30-day Federal Register notices. The scope of the April 2021 umbrella accounts for Medicaid and CHIP State plan amendments, waivers, demonstrations, and reporting. This Federal Register notice seeks public comment on one or more of our collection of information requests that we believe are generic and fall within the scope of the umbrella. Interested persons are invited to submit comments regarding our burden estimates or any other aspect of this collection of information, including: the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
National Institute on Drug Abuse; Notice of Closed Meeting
Document Number: 2023-13057
Type: Notice
Date: 2023-06-20
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2023-13056
Type: Notice
Date: 2023-06-20
Agency: Department of Health and Human Services, National Institutes of Health
Agency Information Collection Request. 30-Day Public Comment Request
Document Number: 2023-13047
Type: Notice
Date: 2023-06-20
Agency: Department of Health and Human Services
In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment.
Submission for OMB Review; 30-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
Document Number: 2023-13082
Type: Notice
Date: 2023-06-20
Agency: Department of Health and Human Services, National Institutes of Health
In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below.
Healthcare Infection Control Practices Advisory Committee (HICPAC); Correction
Document Number: 2023-12990
Type: Notice
Date: 2023-06-20
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Healthcare Infection Control Practices Advisory Committee (HICPAC). This is a virtual meeting. The public is welcomed to listen to the meeting via Zoom; 500 teleconference lines are available. Time will be available for public comment. Registration is required.
Older Americans Act: Grants to State and Community Programs on Aging; Grants to Indian Tribes for Support and Nutrition Services; Grants for Supportive and Nutritional Services to Older Hawaiian Natives; and Allotments for Vulnerable Elder Rights Protection Activities
Document Number: 2023-12829
Type: Proposed Rule
Date: 2023-06-16
Agency: Department of Health and Human Services
The Administration for Community Living (ACL) within The Department of Health and Human Services (``the Department'' or HHS) is issuing this notice of proposed rulemaking (NPRM) to modernize the implementing regulations of the Older Americans Act of 1965 (``the Act'' or OAA), which have not been substantially altered since their promulgation in 1988. These changes advance the policy goals of the Older Americans Act as articulated by Congress, including equity in service delivery, accountability for funds expended, and clarity of administration for the Administration for Community Living and its grantees. Our proposals will ultimately facilitate improved service delivery and enhanced benefits for OAA participants, particularly those in greatest economic need and greatest social need consistent with the statute.
Implementation of the NIH SBIR and STTR Foreign Disclosure Pre-Award and Post-Award Requirements
Document Number: 2023-12854
Type: Notice
Date: 2023-06-16
Agency: Department of Health and Human Services, National Institutes of Health
The National Institutes of Health (NIH) announces publication and serves as Notice for the extramural community on recent policy changes made for the Small Business Innovation Research Program (SBIR) and the Small Business Technology Transfer Program (STTR). This Notice implements additional disclosure requirements and post-award reporting requirements for small business concerns (SBCs) for covered relationships. In addition, this serves as notification of NIH's due diligence program to assess security risks and denial of award when foreign relationships or commitments with countries of concern pose a significant risk as provided in the SBIR and STTR Extension Act of 2022 at https://www.congress.gov/117/plaws/publ183/PLAW-117publ183.pd f under these programs. This policy serves as an update to section 18. Grants to For Profit Organizations of the NIH Grants Policy Statement (GPS) at https://grants.nih.gov/grants/policy/nihgps/HTML5/section_18/ 18_grants_to_for-profit_organizations.htm and will be incorporated in the FY24 publication. In addition, the NIH Application Guide will be updated to reflect instructions for submission of required documentation.
Establishment of the Aging and Neurodegeneration Integrated Review Group
Document Number: 2023-12987
Type: Notice
Date: 2023-06-16
Agency: Department of Health and Human Services, National Institutes of Health
Statement of Delegation of Authority
Document Number: 2023-12983
Type: Notice
Date: 2023-06-16
Agency: Department of Health and Human Services
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2023-12979
Type: Notice
Date: 2023-06-16
Agency: Department of Health and Human Services, National Institutes of Health
Office of the Director, National Institutes of Health; Notice of Closed Meeting
Document Number: 2023-12978
Type: Notice
Date: 2023-06-16
Agency: Department of Health and Human Services, National Institutes of Health
Draft Guidance on Frequently Asked Questions: Limited Institutional Review Board Review and Related Exemptions
Document Number: 2023-12924
Type: Notice
Date: 2023-06-16
Agency: Department of Health and Human Services
The Office for Human Research Protections (OHRP), Office of the Assistant Secretary for Health, is announcing the availability of a draft guidance document titled, ``Frequently Asked Questions: Limited Institutional Review Board Review and Related Exemptions.''
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2023-12940
Type: Notice
Date: 2023-06-16
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Heat-related Changes in Cognitive Performance. This data collection is designed to evaluate and assess the cognitive impacts of heat exposure on workers.
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2023-12939
Type: Notice
Date: 2023-06-16
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of Government information, invites the general public and other Federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled NCEZID Rapid Message Testing & Development System. This collection will enable the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) to test health messages and gather information to inform the development of health messages.
Proposed Data Collection Submitted for Public Comment and Recommendations
Document Number: 2023-12938
Type: Notice
Date: 2023-06-16
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of Government information, invites the general public and other Federal agencies the opportunity to comment on a proposed information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Healthcare Outbreak Prevention and Response Curriculum for Public Health Departments. This data collection will allow CDC to evaluate whether the CDC-developed trainings are reaching the intended audience and achieving the intended goal of strengthening public health workforce capacity to prevent and respond to Healthcare-Associated Infections and Antibiotic Resistance (HAI/AR) outbreaks.
Agency Forms Undergoing Paperwork Reduction Act Review
Document Number: 2023-12937
Type: Notice
Date: 2023-06-16
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Notice of Award of a Single-Source Cooperative Agreement To Fund the National Institute for Communicable Diseases, Republic of South Africa
Document Number: 2023-12963
Type: Notice
Date: 2023-06-16
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces the award of approximately $2,000,000, with an expected total funding of approximately $11,500,000 over a five-Year period, to the National Institute for Communicable Diseases, Republic of South Africa. The award will support research studies on influenza and other respiratory pathogens of public health import in South Africa.
Agency Information Collection Activities: Proposed Collection; Comment Request
Document Number: 2023-12773
Type: Notice
Date: 2023-06-15
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed Meetings
Document Number: 2023-12794
Type: Notice
Date: 2023-06-15
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Document Number: 2023-12793
Type: Notice
Date: 2023-06-15
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Neurological Disorders and Stroke, Notice of Closed Meetings
Document Number: 2023-12792
Type: Notice
Date: 2023-06-15
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Document Number: 2023-12791
Type: Notice
Date: 2023-06-15
Agency: Department of Health and Human Services, National Institutes of Health
Questions and Answers About Dietary Guidance Statements in Food Labeling: Draft Guidance for Industry; Extension of the Comment Period
Document Number: 2023-12790
Type: Notice
Date: 2023-06-15
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is extending the comment period for the draft guidance entitled ``Questions and Answers About Dietary Guidance Statements in Food Labeling: Draft Guidance for Industry,'' that appeared in the Federal Register of March 27, 2023. We are taking this action in response to requests for an extension to allow interested persons additional time to submit comments.
National Human Genome Research Institute; Notice of Closed Meeting
Document Number: 2023-12823
Type: Notice
Date: 2023-06-15
Agency: Department of Health and Human Services, National Institutes of Health
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Quantitative Research on Front of Package Labeling on Packaged Foods
Document Number: 2023-12820
Type: Notice
Date: 2023-06-15
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (PRA).
Content of Premarket Submissions for Device Software Functions; Guidance for Industry and Food and Drug Administration Staff; Availability
Document Number: 2023-12723
Type: Notice
Date: 2023-06-14
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled ``Content of Premarket Submissions for Device Software Functions.'' This guidance document is intended to provide information regarding the recommended documentation sponsors should include in premarket submissions for FDA's evaluation of safety and effectiveness of device software functions, which are functions that meet the definition of a device under the Federal Food, Drug, and Cosmetic Act (FD&C Act). This document replaces FDA's ``Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices'' issued on May 11, 2005, and updates FDA's thinking related to the documentation FDA recommends sponsors include for the review of device software functions in premarket submissions.
Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Data System for Organ Procurement and Transplantation Network, OMB No. 0915-0157-Revision
Document Number: 2023-12719
Type: Notice
Date: 2023-06-14
Agency: Department of Health and Human Services, Health Resources and Services Administration
In compliance with of the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 2023-12717
Type: Notice
Date: 2023-06-14
Agency: Department of Health and Human Services, National Institutes of Health
Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Be The Match® Patient Support Center Survey-Revision
Document Number: 2023-12666
Type: Notice
Date: 2023-06-14
Agency: Department of Health and Human Services, Health Resources and Services Administration
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
Announcing the Annual Meeting of the President's Council on Sports, Fitness & Nutrition
Document Number: 2023-12692
Type: Notice
Date: 2023-06-14
Agency: Department of Health and Human Services
As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services (HHS) is hereby giving notice that the President's Council on Sports, Fitness & Nutrition (PCSFN) will hold its annual meeting. The meeting will be open to the public.
Supplemental Evidence and Data Request on The Effect of Protein Intake on Health
Document Number: 2023-12678
Type: Notice
Date: 2023-06-14
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our review on The Effect of Protein Intake on Health, which is currently being conducted by the AHRQ's Evidence-based Practice Centers (EPC) Program. Access to published and unpublished pertinent scientific information will improve the quality of this review.
Supplemental Evidence and Data Request on Evaluation of Dietary Protein Intake Requirements
Document Number: 2023-12677
Type: Notice
Date: 2023-06-14
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our review on Evaluation of Dietary Protein Intake Requirements, which is currently being conducted by the AHRQ's Evidence-based Practice Centers (EPC) Program. Access to published and unpublished pertinent scientific information will improve the quality of this review.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.